IperionX Statistics
Total Valuation
IperionX has a market cap or net worth of $957.93 million. The enterprise value is $894.28 million.
| Market Cap | 957.93M |
| Enterprise Value | 894.28M |
Important Dates
The next estimated earnings date is Thursday, September 24, 2026.
| Earnings Date | Sep 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IperionX has 339.38 million shares outstanding. The number of shares has increased by 35.14% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 339.38M |
| Shares Change (YoY) | +35.14% |
| Shares Change (QoQ) | +7.59% |
| Owned by Insiders (%) | 17.36% |
| Owned by Institutions (%) | 72.35% |
| Float | 270.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 66.45 |
| PB Ratio | 8.85 |
| P/TBV Ratio | 10.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.03, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.03 |
| Quick Ratio | 3.88 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.48 |
Financial Efficiency
Return on equity (ROE) is -50.42% and return on invested capital (ROIC) is -31.10%.
| Return on Equity (ROE) | -50.42% |
| Return on Assets (ROA) | -28.24% |
| Return on Invested Capital (ROIC) | -31.10% |
| Return on Capital Employed (ROCE) | -49.46% |
| Weighted Average Cost of Capital (WACC) | 11.83% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.80M |
| Employee Count | 30 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.10% in the last 52 weeks. The beta is 1.35, so IperionX's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | -3.10% |
| 50-Day Moving Average | 34.86 |
| 200-Day Moving Average | 39.66 |
| Relative Strength Index (RSI) | 41.73 |
| Average Volume (20 Days) | 326,033 |
Short Selling Information
The latest short interest is 702,344, so 2.43% of the outstanding shares have been sold short.
| Short Interest | 702,344 |
| Short Previous Month | 650,221 |
| Short % of Shares Out | 2.43% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.09 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -55.34M |
| Pretax Income | -53.88M |
| Net Income | -53.88M |
| EBITDA | -52.64M |
| EBIT | -55.34M |
| Earnings Per Share (EPS) | -$0.16 |
Balance Sheet
The company has $65.83 million in cash and $4.46 million in debt, with a net cash position of $61.37 million or $0.18 per share.
| Cash & Cash Equivalents | 65.83M |
| Total Debt | 4.46M |
| Net Cash | 61.37M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | 108.20M |
| Book Value Per Share | 0.32 |
| Working Capital | 52.30M |
Cash Flow
In the last 12 months, operating cash flow was -$26.75 million and capital expenditures -$28.54 million, giving a free cash flow of -$55.29 million.
| Operating Cash Flow | -26.75M |
| Capital Expenditures | -28.54M |
| Depreciation & Amortization | 2.70M |
| Net Borrowing | -858,069 |
| Free Cash Flow | -55.29M |
| FCF Per Share | -$0.16 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IperionX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.14% |
| Shareholder Yield | -35.14% |
| Earnings Yield | -5.62% |
| FCF Yield | -5.77% |
Analyst Forecast
The average price target for IperionX is $58.00, which is 95.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $58.00 |
| Price Target Difference | 95.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |